These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 20690892)

  • 1. Leptin gene therapy in the fight against diabetes.
    Wang Y; Asakawa A; Inui A; Kosai K
    Expert Opin Biol Ther; 2010 Oct; 10(10):1405-14. PubMed ID: 20690892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pivotal role of leptin-hypothalamus signaling in the etiology of diabetes uncovered by gene therapy: a new therapeutic intervention?
    Kalra SP
    Gene Ther; 2011 Apr; 18(4):319-25. PubMed ID: 21209624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central leptin gene therapy, a substitute for insulin therapy to ameliorate hyperglycemia and hyperphagia, and promote survival in insulin-deficient diabetic mice.
    Kojima S; Asakawa A; Amitani H; Sakoguchi T; Ueno N; Inui A; Kalra SP
    Peptides; 2009 May; 30(5):962-6. PubMed ID: 19428774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct delivery of leptin to the hypothalamus using recombinant adeno-associated virus vectors results in increased therapeutic efficacy.
    Lundberg C; Jungles SJ; Mulligan RC
    Nat Biotechnol; 2001 Feb; 19(2):169-72. PubMed ID: 11175734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cell therapy and gene therapy in diabetes mellitus].
    Seufert J
    MMW Fortschr Med; 2004 May; 146(20):39-40. PubMed ID: 15344732
    [No Abstract]   [Full Text] [Related]  

  • 6. Diabetes epidemiology as a tool to trigger diabetes research and care.
    Zimmet PZ
    Diabetologia; 1999 May; 42(5):499-518. PubMed ID: 10333041
    [No Abstract]   [Full Text] [Related]  

  • 7. Leptin gene transfer in the hypothalamus enhances longevity in adult monogenic mutant mice in the absence of circulating leptin.
    Boghossian S; Ueno N; Dube MG; Kalra P; Kalra S
    Neurobiol Aging; 2007 Oct; 28(10):1594-604. PubMed ID: 17011078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of adiponectin-encoding plasmid DNA and gene therapy of non-obese type 2 diabetes mellitus.
    Nan MH; Park JS; Myung CS
    J Drug Target; 2010 Jan; 18(1):67-77. PubMed ID: 19708766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Do we need new ways of cell and gene treatment of diabetics? - Pro].
    Seufert J
    Dtsch Med Wochenschr; 2002 May; 127(18):978. PubMed ID: 11987019
    [No Abstract]   [Full Text] [Related]  

  • 10. Transgenic complementation of leptin receptor deficiency. II. Increased leptin receptor transgene dose effects on obesity/diabetes and fertility/lactation in lepr-db/db mice.
    Chua SC; Liu SM; Li Q; Sun A; DeNino WF; Heymsfield SB; Guo XE
    Am J Physiol Endocrinol Metab; 2004 Mar; 286(3):E384-92. PubMed ID: 14600075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Do we need new ways of cell and gene treatment of diabetics? - Contra].
    Lüddeke HJ
    Dtsch Med Wochenschr; 2002 May; 127(18):979. PubMed ID: 11987020
    [No Abstract]   [Full Text] [Related]  

  • 12. Abnormalities in glucose metabolism in patients with schizophrenia treated with atypical antipsychotic medications.
    Elias AN; Hofflich H
    Am J Med; 2008 Feb; 121(2):98-104. PubMed ID: 18261494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic insulin gene therapy prevents deterioration of vascular function and improves adipocytokine profile in STZ-diabetic rats.
    Thulé PM; Campbell AG; Kleinhenz DJ; Olson DE; Boutwell JJ; Sutliff RL; Hart CM
    Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E114-E122. PubMed ID: 16118252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of leptin levels in plasma and their reliance on other hormonal factors affecting tissue fat levels in people with various levels of endogenous cotisol].
    Robaczyk MG
    Ann Acad Med Stetin; 2002; 48():283-300. PubMed ID: 14601484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes, insulin resistance and dyslipidaemia in lipodystrophic HIV-infected patients on highly active antiretroviral therapy (HAART).
    Vigouroux C; Gharakhanian S; Salhi Y; Nguyen TH; Chevenne D; Capeau J; Rozenbaum W
    Diabetes Metab; 1999 Sep; 25(3):225-32. PubMed ID: 10499191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmid-based gene therapy of diabetes mellitus.
    Prud'homme GJ; Draghia-Akli R; Wang Q
    Gene Ther; 2007 Apr; 14(7):553-64. PubMed ID: 17215847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose intolerance and insulin resistance in patients with liver disease.
    Collins JR; Crofford OB
    Arch Intern Med; 1969 Aug; 124(2):142-8. PubMed ID: 5797072
    [No Abstract]   [Full Text] [Related]  

  • 18. miR-24 in diabetes.
    Xiang Y
    Oncotarget; 2015 Jul; 6(19):16816-7. PubMed ID: 26219469
    [No Abstract]   [Full Text] [Related]  

  • 19. Leptin revisited: its mechanism of action and potential for treating diabetes.
    Coppari R; Bjørbæk C
    Nat Rev Drug Discov; 2012 Sep; 11(9):692-708. PubMed ID: 22935803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transgenic approach toward leptin biology: the clinical implications of leptin for the treatment of obesity-associated diabetes and obesity-related hypertension.
    Masuzaki H; Ogawa Y; Aizawa-Abe M; Nakao K
    Endocr J; 2002 Apr; 49(2):109-19. PubMed ID: 12081228
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.